Best Medical Stocks To Own Right Now

tags:STAA,NOAH,CDK,SSBI,MOD,MTCH,

Fibrocell Science (NASDAQ:FCSC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm presently has a $2.00 price target on the stock. Zacks Investment Research‘s price objective points to a potential upside of 6.38% from the stock’s previous close.

According to Zacks, “Fibrocell Science, Inc. is an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs. Fibrocell’s most advanced drug candidate, azficel-T, uses its FDA-approved proprietary autologous fibroblast technology and is in a Phase II clinical trial for the treatment of chronic dysphonia resulting from vocal cord scarring or atrophy. In collaboration with Intrexon Corporation, a leader in synthetic biology, Fibrocell is also developing gene therapies for orphan skin diseases using gene-modified autologous fibroblasts. The Company’s lead orphan gene-therapy drug candidate, FCX-007, is in late stage pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Fibrocell is also in pre-clinical development of FCX-013, its second gene-therapy drug candidate, for the treatment of linear scleroderma. “

Best Medical Stocks To Own Right Now: STAAR Surgical Company(STAA)

Advisors' Opinion:

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday. Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each. Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55. Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months. Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75. STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results. Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday. China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday. YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings. MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings. Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share. Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701. Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings. The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings. Ca
• [By Lisa Levin]

  STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.

  Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90. Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months. Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00. Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday. STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results. Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday. Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share. YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings. ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15. MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings. Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings. TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results. Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings. TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results. Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings. Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results. Logitech International S.A. (NASDAQ: LOGI)
• [By Joseph Griffin]

  STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

• [By Keith Speights]

  Three big healthcare winners this week were STAAR Surgical (NASDAQ:STAA), Tenet Healthcare (NYSE:THC), and Portola Pharmaceuticals (NASDAQ:PTLA). Each of these stocks jumped more than 24% over the last few days. Are STAAR Surgical, Tenet, and Portola smart picks for investors after the stocks' huge gains?

• [By Keith Speights]

  Shares of STAAR Surgical Company (NASDAQ:STAA) were up 21.5% as of 11:25 a.m. EDT on Thursday. The big jump occurred after the maker of implantable lenses announced its second-quarter earnings results on Wednesday evening.

Best Medical Stocks To Own Right Now: Noah Holdings Ltd.(NOAH)

Advisors' Opinion:

• [By Max Byerly]

  Noah Holdings (NYSE:NOAH)’s share price hit a new 52-week high and low on Monday . The stock traded as low as $57.81 and last traded at $57.76, with a volume of 191661 shares traded. The stock had previously closed at $54.50.

• [By Max Byerly]

  Noah (NYSE:NOAH) was downgraded by analysts at Nomura from a buy rating to a neutral rating.

  TherapeuticsMD (NASDAQ:TXMD) was given a $12.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

• [By Ethan Ryder]

  Noah Coin (CURRENCY:NOAH) traded down 3.6% against the U.S. dollar during the 24-hour period ending at 21:00 PM Eastern on July 1st. In the last week, Noah Coin has traded up 15% against the U.S. dollar. One Noah Coin token can currently be purchased for about $0.0041 or 0.00000065 BTC on major exchanges. Noah Coin has a total market capitalization of $0.00 and approximately $375,126.00 worth of Noah Coin was traded on exchanges in the last day.

• [By Stephan Byrd]

  Noah Coin (CURRENCY:NOAH) traded down 0.2% against the US dollar during the 24-hour period ending at 10:00 AM Eastern on May 14th. Noah Coin has a market capitalization of $0.00 and approximately $2.39 million worth of Noah Coin was traded on exchanges in the last day. One Noah Coin token can currently be purchased for approximately $0.0083 or 0.00000095 BTC on cryptocurrency exchanges. Over the last seven days, Noah Coin has traded down 8.5% against the US dollar.

• [By Max Byerly]

  Noah Coin (CURRENCY:NOAH) traded 3.3% higher against the US dollar during the twenty-four hour period ending at 20:00 PM Eastern on February 3rd. During the last seven days, Noah Coin has traded 10% lower against the US dollar. Noah Coin has a total market cap of $6.11 million and approximately $75,297.00 worth of Noah Coin was traded on exchanges in the last 24 hours. One Noah Coin token can now be purchased for $0.0002 or 0.00000005 BTC on popular cryptocurrency exchanges including YoBit, DDEX, Mercatox and Livecoin.

• [By Shane Hupp]

  Noah (NYSE: NOAH) and MAN Grp PLC/ADR (OTCMKTS:MNGPY) are both mid-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Best Medical Stocks To Own Right Now: CDK Global, Inc.(CDK)

Advisors' Opinion:

• [By Motley Fool Transcribers]

  CDK Global Inc  (NASDAQ:CDK)Q2 2019 Earnings Conference CallFeb. 05, 2019, 8:30 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  CDK Global Inc (NASDAQ:CDK) shares hit a new 52-week low during trading on Wednesday after Morgan Stanley lowered their price target on the stock from $75.00 to $68.00. Morgan Stanley currently has an equal weight rating on the stock. CDK Global traded as low as $59.84 and last traded at $60.56, with a volume of 54440 shares changing hands. The stock had previously closed at $60.77.

• [By Stephan Byrd]

  Traders bought shares of CDK Global Inc (NASDAQ:CDK) on weakness during trading on Thursday. $24.87 million flowed into the stock on the tick-up and $8.74 million flowed out of the stock on the tick-down, for a money net flow of $16.13 million into the stock. Of all companies tracked, CDK Global had the 12th highest net in-flow for the day. CDK Global traded down ($0.31) for the day and closed at $62.85

Best Medical Stocks To Own Right Now: Summit State Bank(SSBI)

Advisors' Opinion:

• [By Max Byerly]

  ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

  Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Best Medical Stocks To Own Right Now: Modine Manufacturing Company(MOD)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Modine Manufacturing (MOD)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Modum (CURRENCY:MOD) traded 1% higher against the U.S. dollar during the 24-hour period ending at 23:00 PM ET on May 7th. One Modum token can currently be purchased for $3.01 or 0.00031911 BTC on cryptocurrency exchanges including Kucoin, IDEX, Binance and Mercatox. Over the last seven days, Modum has traded 9% higher against the U.S. dollar. Modum has a total market cap of $55.00 million and $789,835.00 worth of Modum was traded on exchanges in the last 24 hours.

• [By Motley Fool Transcribers]

  Modine Manufacturing Co  (NYSE:MOD)Q3 2019 Earnings Conference CallFeb. 01, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Lisa Levin] Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity. Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process. Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results. Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58. Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009. The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613. Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan. AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65. nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results. Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303. Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake. HUYA Inc. (NYSE: HUYA) gained 13.1

Best Medical Stocks To Own Right Now: Match Group, Inc.(MTCH)

Advisors' Opinion:

• [By Chris Lange]

  Match Group Inc. (NASDAQ: MTCH) saw its short interest decrease to 25.06 million from the previous 25.52 million. Shares were trading at $49.54, in a 52-week range of $18.11 to $49.98.

• [By Jeremy Bowman]

  One possible acquisition could be Match Group (NASDAQ:MTCH), the parent of Tinder and a leader in the online dating industry, whose valuation has ballooned to $16 billion. Facebook said earlier this year it would launch its own dating product, but taking over Match would be an easier way to assert its power in the industry. The two businesses have a natural overlap, and Facebook's advertising acumen could benefit the company's ad-based products. However, companies like Match could be reluctant to sell to Facebook after a year's worth of scandals that have damaged Facebook's image and user trust. Regulators might also be reluctant to approve further acquisitions given the company's formidable market power. A Facebook takeover of Match could also turn off online daters who don't trust Facebook with their personal information and might resent a further incursion from the social media giant into their lives.

• [By Demitrios Kalogeropoulos]

  Dating app specialist Match Group (NASDAQ:MTCH) trailed the market last month, falling 13% compared to a 2% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

• [By Danny Vena]

  There was a lot to like when Match Group (NASDAQ:MTCH) reported its second-quarter financial results on Aug. 7. The company generated revenue of $421 million, up 36% year over year, while operating income jumped 81% compared to the prior-year quarter. Diluted earnings per share of $0.45 soared 165% year over year, as subscriber growth of 27% drove its users past 7.7 million.

• [By Chris Lange]

  Match Group Inc. (NASDAQ: MTCH) is set to release its most recent quarterly results on Tuesday. The consensus forecast calls for $0.23 in EPS and $384.98 million in revenue. Shares traded on Friday's close at $34.82. The consensus price target is $42.56, and the 52-week range is $16.57 to $48.65.

• [By Harsh Chauhan]

  Shares of Match Group (NASDAQ:MTCH) are down this year after delivering impressive gains in 2016, as analysts fear the company's high-growth days might be coming to an end. The Tinder parent's top-line guidance of $1.26 billion to $1.31 billion for the year has raised a red flag, as Wall Street was looking for $1.41 billion in revenue.